Homology Medicines, Inc. Insider Trading for December 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Homology Medicines, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Homology Medicines, Inc. for December 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 27 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.95 | 151,233 | 3,319,579 | 1,766,106 | 1.9 M to 1.8 M (-7.89 %) |
| Dec 27 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.95 | 198,767 | 4,362,956 | 2,321,199 | 2.5 M to 2.3 M (-7.89 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 56,595 | 1,235,435 | 1,917,339 | 2 M to 1.9 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 74,384 | 1,623,758 | 2,519,966 | 2.6 M to 2.5 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 9,130 | 196,297 | 1,973,934 | 2 M to 2 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 11,999 | 257,981 | 2,594,350 | 2.6 M to 2.6 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 5,454 | 118,219 | 1,983,064 | 2 M to 2 M (-0.27 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 7,168 | 155,371 | 2,606,349 | 2.6 M to 2.6 M (-0.27 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 56,595 | 1,235,435 | 1,917,339 | 2 M to 1.9 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.83 | 74,384 | 1,623,758 | 2,519,966 | 2.6 M to 2.5 M (-2.87 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 9,130 | 196,297 | 1,973,934 | 2 M to 2 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.50 | 11,999 | 257,981 | 2,594,350 | 2.6 M to 2.6 M (-0.46 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 5,454 | 118,219 | 1,983,064 | 2 M to 2 M (-0.27 %) |
| Dec 23 2019 | FIXX | Homology Medicines ... | Flynn James E | 10% Owner | Sell | S | 21.68 | 7,168 | 155,371 | 2,606,349 | 2.6 M to 2.6 M (-0.27 %) |
| Dec 13 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Option Exercise | A | 19.92 | 358,000 | 7,131,360 | 358,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Cohn Gabriel | Chief Medical Offic ... | Option Exercise | A | 19.92 | 15,000 | 298,800 | 15,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Option Exercise | A | 19.92 | 110,000 | 2,191,200 | 110,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Kelly Timothy P | See Remarks | Option Exercise | A | 19.92 | 112,000 | 2,231,040 | 112,000 | |
| Dec 13 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | A | 19.92 | 111,000 | 2,211,120 | 111,000 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Cohn Gabriel | Chief Medical Offic ... | Option Exercise | A | 17.14 | 120,000 | 2,056,800 | 120,000 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 121,404 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Option Exercise | M | 0.64 | 6,000 | 3,840 | 127,404 | |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 16.21 | 6,000 | 97,266 | 0 | 6 K to 0 (-100.00 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Sell | S | 16.00 | 6,000 | 96,000 | 0 | 6 K to 0 (-100.00 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Smith W Bradford | CFO, Treasurer & Se ... | Buy | M | 0.64 | 6,000 | 3,840 | 6,000 | 0 to 6 K |
| Dec 03 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.25 | 12,500 | 203,176 | 102,505 | 115 K to 102.5 K (-10.87 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | TZIANABOS ARTHUR | President & CEO | Sell | S | 16.04 | 12,500 | 200,559 | 115,005 | 127.5 K to 115 K (-9.80 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 16.23 | 9,300 | 150,970 | 163,150 | 172.5 K to 163.2 K (-5.39 %) |
| Dec 03 2019 | FIXX | Homology Medicines ... | Seymour Albert | Chief Scientific Of ... | Sell | S | 16.06 | 9,300 | 149,390 | 172,450 | 181.8 K to 172.5 K (-5.12 %) |